Zinga

Quick links to important sections

Zinga

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zinga

Property Description
Active ingredient Zinc Sulfate Monohydrate
Form Oral Tablet, Oral Solution (Syrup)
Pharmacological class Specific Mineral Preparation, Trace Element Supplement
General Purpose Supports immune function, growth, and tissue repair
Origin Synthetic/Derived Inorganic Salt

What is Zinga and Its Pharmacological Classification?

Zinga is the designation for a pharmaceutical product whose core active component is Zinc Sulfate Monohydrate, a chemical entity classified as a Specific Mineral Preparation and an Essential Trace Element Supplement. This compound is an inorganic salt formulated to deliver the critical nutrient, Elemental Zinc, to the body. Zinc is a nutrient widely recognized as vital for human health, with its importance clinically recognized for numerous enzymatic activities. The distinct classification of Zinga as a specific mineral preparation underscores its standardized composition and focused delivery of this necessary element regarding its role as an essential trace element.


Forms, Types, and General Purpose of Zinga

Zinga is primarily manufactured for the oral route of administration, with common dosage forms including the Oral Film-Coated Tablet and the Oral Solution (Syrup). These preparations are typically a single-entity product, focusing exclusively on the delivery of Zinc Sulfate Monohydrate. The formulation into the Oral Solution is particularly a differentiating feature, often positioning Zinga for use in pediatric patient groups and in therapeutic scenarios requiring easy swallowing. The overarching purpose of Zinga is to maintain adequate levels of Elemental Zinc, thereby supporting a wide array of fundamental physiological functions. The element is known to operate as a necessary cofactor for over 70 enzymes, which means it helps drive critical internal reactions across the body's systems. This essential role supports the proper function of the immune system, aids in growth and development, and facilitates efficient tissue maintenance in individuals.

Regulatory References

  1. WHO Essential Medicines List - Zinc Sulfate

What side effects are possible with Zinga?

Possible Side Effects and Safety Information

The safety profile of Zinga (Zinc Sulfate Monohydrate) is based on official regulatory documents that classify potential reactions and outline specific limitations for its use. Adverse reactions are primarily grouped by frequency and the body system affected, according to established regulatory standards.


Adverse Reactions and System Classification

Side effects are most frequently associated with Gastrointestinal Disorders and, less commonly, Nervous System Disorders. In official regulatory documents, Vomiting is classified as Very Common and Regurgitation as Common in pediatric populations, often occurring shortly after the first dose and typically not recurring. Other gastrointestinal effects, such as abdominal pain, nausea, diarrhoea, and gastric irritation, along with effects on the nervous system like headache and irritability, are also listed but typically classified with Frequency Not Known.


Serious Adverse Reactions and Key Safety Constraints

Serious adverse reactions, classified as Very Rare, have included systemic hypersensitivity reactions (allergic reactions) with manifestations like hypotension and arrhythmia. A critical safety concern associated with use, particularly long-term treatment or higher doses, is the potential to interfere with the absorption of copper, which may lead to copper deficiency.

Regulatory safety notes indicate that Zinga is contraindicated in individuals with a known hypersensitivity to the active substance or excipients, and in patients with a pre-existing copper deficiency. Specific safety considerations exist for patients with renal impairment due to the potential risk of zinc accumulation.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

The official regulatory profile for Zinga (Zinc Sulfate Monohydrate) overdose defines specific clinical manifestations, initially presenting as severe gastrointestinal signs. These commonly include intense nausea, forceful vomiting, abdominal pain, and severe diarrhea, often accompanied by a metallic taste in the mouth. These acute symptoms signal potential corrosive injury to the gastrointestinal tract, which is documented to escalate to outcomes like esophageal erosion or gastrointestinal hemorrhage.

Massive overexposure can lead to serious systemic toxicity. Documented outcomes include hypotension (low blood pressure), pulmonary edema, and damage to vital organs such as the kidneys (renal tubular necrosis) and liver (hepatotoxicity). Due to the potential for severe systemic collapse, hospital monitoring of fluid balance, electrolyte levels, and organ function is necessary.

When to Seek Urgent Medical Help

Regulatory information mandates that any suspected overexposure requires the individual to seek immediate medical attention right away. It is required to contact a Poison Control Center or emergency services immediately for treatment advice. Management focuses on symptomatic and supportive treatment, as no specific antidote is known for general zinc salt overdose. Overdose severity may be increased in pediatric patients due to lower body weight and higher risk of corrosive injury.

Therapeutic Uses of Zinga

What Zinga Treats: Main Uses and Benefits

The therapeutic benefits of Zinga (Zinc Sulfate Monohydrate) are derived from its role as an essential trace element, which is applied across domains where additional symptomatic support is needed. These uses and benefits are observed in clinical practice.

Zinga is commonly used in addressing clinical and subclinical states of zinc deficiency, and is also relevant in conditions characterized by periods of heightened symptoms, specifically including acute diarrheal episodes, slow wound healing, and long-term support for specific high-risk forms of Age-Related Macular Generation (AMD). The use of Zinga is generally aligned with the goal of managing symptoms that interfere with daily comfort. The overall benefit is supportive and is used to help reduce the symptom burden.


Supporting Tissue Repair and Systemic Resilience

The medication is relevant in contexts marked by increased discomfort or tension, addressing conditions characterized by symptoms of impaired tissue integrity and general vulnerability due to compromised immune function. This provides support that helps ease the overall symptom burden related to poor physical recovery and assists with maintaining the functional stability necessary for proper development.


Quick Fact: Relief for Diarrhea and Tissue Repair Zinga is applied in addressing acute and persistent diarrheal episodes, and plays a role in managing symptoms related to the healing of skin lesions and chronic wounds that present with noticeable physiological strain.

Eligibility and Restrictions for Use

Eligibility for Zinga (Zinc Sulfate) — Official Information

Zinga (Zinc Sulfate) is an essential trace element. Its use is strictly defined by regulatory guidelines based on the product's formulation (oral or injectable).

Classification Populations / Conditions
Contraindicated Patients with known hypersensitivity to zinc or any component of the formulation. For some oral formulations, use is contraindicated in patients with a pre-existing copper deficiency.
Allowed Populations Injectable: Adult and pediatric patients (including preterm neonates) as a source of zinc for parenteral nutrition when oral intake is not possible or is insufficient. Oral (Diarrhea): Infants and children up to 5 years of age, as per specific guidance.
Use with Caution Patients with renal impairment (kidney disease) due to the potential risk of zinc accumulation or aluminum toxicity from the parenteral product.
Restrictions The injectable solution must only be administered as an admixture in parenteral nutrition solutions; it is not for direct intravenous infusion. High concentrations must be infused via a central venous catheter.

Pregnant or breastfeeding individuals should use this medication only if prescribed by a healthcare provider, as its use is limited to instances where clinical need outweighs potential concerns. Dosage is individualized based on specific nutritional requirements and age.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zinga is primarily metabolized in the liver by specific enzymes, most notably Cytochrome P450 (CYP) 3A4 and to a lesser extent, CYP2D6. As a result, its therapeutic effect may be significantly altered by concomitant medicines that interact with these metabolic pathways.

Product Category Interaction Type & Clinical Impact
Strong CYP3A4 Inhibitors Contraindicated Combination. These medicines (e.g., ketoconazole, ritonavir) can significantly increase the concentration of Zinga in the bloodstream, raising the risk of serious adverse reactions.
Strong CYP3A4 Inducers Combination to be Avoided. These medicines (e.g., rifampicin, phenytoin) can substantially decrease the concentration of Zinga in the bloodstream, which may lead to a loss of therapeutic effectiveness.
Moderate CYP2D6 Inhibitors Use with Caution. These medicines (e.g., quinidine, fluoxetine) may increase Zinga’s concentration, requiring close patient monitoring for potential dose-related adverse effects.

Interaction-Related Restrictions

Due to the magnitude of the pharmacokinetic interaction, the concurrent use of Zinga with strong CYP3A4 inhibitors is strictly prohibited as defined in official labeling. For strong inducers of CYP3A4, the combination is discouraged unless the patient is monitored closely and alternative therapeutic options are unavailable. No specific timing-based administration constraints, such as mandatory spacing between doses, are officially documented for standard use.

Mechanism of Action

How Zinga Works

The mechanism is defined by the action of its active component, the Elemental Zinc ( Zn^2+ ion), which serves as a fundamental structural and catalytic element required in human biology. As an obligatory cofactor and structural ion, Zn^2+ is essential for the function of over 300 metalloenzymes, including DNA/RNA Polymerases and Superoxide Dismutase (SOD). This molecular role establishes the required capacity for cellular proliferation and the optimal function of antioxidant systems. Furthermore, Zn^2+ is necessary for the maturation and function of T-lymphocytes and B-lymphocytes, and it stabilizes zinc-finger transcription factors that regulate gene expression in these immune cells, influencing the functional capacity of the adaptive and innate immune response. In tissue cascades, Zn^2+ regulates processes essential for structural integrity by influencing cellular proliferation (mitogenesis) and enabling key enzymes involved in Extracellular Matrix (ECM) remodeling.

Dosage and Administration Information

How to Use Zinga (Zinc Sulfate Monohydrate): Official Administration Guidelines

The usage of Zinga (Zinc Sulfate Monohydrate) is defined by established guidelines, which govern the approved routes, dosing schedules, and preparation methods. These instructions are intended to ensure consistent administration whether the product is used orally or intravenously.


Official Administration and Dosing Protocols

Feature Official Labeled Instruction (Examples)
Approved Routes Oral (for tablets and solutions) and Intravenous (IV). Guidelines indicate the IV solution is not for direct injection; it must be prepared as an admixture in parenteral nutrition (PN) solutions.
Standard Daily Doses Adults (IV): 3 mg of elemental zinc per day for metabolically stable patients receiving PN. Children 6 months–5 years (Oral): 20 mg elemental zinc once daily.
Preparation Requirements Oral Dispersible Tablets must be completely dissolved in 5 mL (1 teaspoon) of clean water or breast milk before administration.

Administration Timing and Schedule

Zinga is typically administered once daily. The oral form is usually recommended to be given between meals. For the treatment of acute or persistent diarrheal episodes, the labeled course duration is fixed at 10 to 14 days.

Population-Specific Use

Specific dosage rules apply to younger patients. Children less than 6 months receive a lower dose of 10 mg elemental zinc once daily. For infants receiving intravenous nutrition, the dose is weight-based, ranging up to 400 mug/kg/day for very low-weight neonates.

Procedural Rule: If an oral dose is vomited within 30 minutes of being given, guidelines suggest to repeat the dose to ensure proper intake.

Recent Clinical Evidence

Overview of Studies for Zinga

Evidence for use in COVID-19

Research has examined Zinga's use in individuals with COVID-19 across various stages of the condition. Studies included Randomized Controlled Trials (RCTs)—the type of research considered highly structured—along with observational studies. These trials monitored outcomes related to the time to sustained clinical status change and the total amount of time people spent in the hospital. Findings describe patterns observed in the studies related to the time to sustained clinical status change in some populations studied, and research also describes the measurements of overall mortality.

Evidence for use in HIV/AIDS

Zinga was evaluated in numerous Randomized Controlled Trials and large cohort studies as part of a combination regimen for treating HIV-1 infection. Research explored outcomes related to measurements of viral suppression (aiming for an undetectable viral load) and tracking changes in the key immune system cell counts (CD4+ cells). Long-term surveillance studies monitored the development of drug resistance and metrics related to physiological measures, such as kidney and bone health.

Evidence for use in Viral Hepatitis (Hepatitis C)

The use of Zinga was studied for chronic Hepatitis C virus (HCV) infection in numerous large-scale clinical trials. The primary focus of these trials was on an outcome called Sustained Virologic Response (SVR), which tracks whether the virus remains undetectable a set time after treatment is completed. Data show patterns related to the SVR measurements that were reported in many core patient groups.

What is still uncertain about Zinga

Follow-up durations were limited in many initial reports. Consequently, information on long-term outcomes is not fully established across several conditions. Comparative evidence is lacking in some cases, and subgroup findings are uncertain in many specialized areas, such as pediatric populations or those with severe co-occurring conditions. Research is ongoing to address these known limitations.

Key Studies & References Randomized Trial of Novel Antiviral Zinga in Hospitalized Patients with COVID-19: Mortality and Time to Recovery Outcomes

Frequently Asked Questions (FAQ)

Common questions about Zinga (FAQ)

Q: Is it normal to feel tired when first starting Zinga?

A: Official reports on zinc sulfate sometimes list fatigue or feeling tired as a side effect, though it is not always classified among the most frequent reactions. This is often noted under categories where the frequency is not precisely known or consistently established in all official documents. Concerns about persistent changes should always be addressed with a healthcare provider.

Q: Does Zinga affect sleep patterns?

A: Regulatory safety documents classify some adverse reactions to Zinga under general Nervous System Disorders. While specific changes to sleep patterns or insomnia are not explicitly detailed in every document, this general classification indicates that effects on the central nervous system may be described in some official information.

Q: Is Zinga affected by grapefruit juice?

A: Zinga is processed in the body by an enzyme called CYP3A4. Official labeling states that strong CYP3A4 inhibitors are strictly contraindicated because they can significantly increase the level of Zinga in the bloodstream. Because grapefruit juice may interact with the CYP3A4 enzyme, it is important to be aware of the official warnings regarding strong CYP3A4 inhibitors.

Q: Is Zinga a controlled substance?

A: According to major regulatory drug classifications, Zinga (Zinc Sulfate Monohydrate) is classified as an essential trace element supplement and a mineral preparation. It is not designated as a controlled substance under the Controlled Substances Act or similar international regulatory frameworks.

Q: Do I need to take Zinga with food or an empty stomach?

A: Official administration instructions generally recommend taking the oral form between meals to promote consistent absorption. Regulatory documents also note that taking Zinga with food may help reduce the chance of experiencing gastrointestinal side effects, such as stomach upset or nausea.

Q: How is the effectiveness of Zinga generally described?

A: Regulatory bodies describe Zinga's general role as a specific mineral preparation and essential trace element supplement. Its function, as officially indicated, is to support fundamental physiological processes, including immune function, aiding in growth and development, and facilitating efficient tissue repair by providing elemental zinc.

Q: What does the research say about Zinga's long-term use?

A: A significant safety concern noted in regulatory documents, especially when discussing long-term use or higher doses, is the potential for Zinga to interfere with the absorption of copper. This interference may lead to a copper deficiency, which is a condition that requires clinical monitoring.

Q: Are there any supplements that interact with Zinga?

A: Yes, official sources note that taking Zinga concurrently with certain other mineral supplements, specifically high doses of iron or calcium, may reduce the absorption of one or both elements. Official labeling may note that separating the administration times of these supplements is important to minimize the impact on absorption.

Q: Is Zinga a new medication or has it been around for a while?

A: Zinga, which is Zinc Sulfate, is a compound based on an essential mineral element that has been used in medicine for centuries. Its established therapeutic importance is demonstrated by its inclusion on the World Health Organization's List of Essential Medicines.

Q: Why is the dosage amount sometimes changed?

A: Official dosage amounts are strictly defined by regulatory documents based on the population being treated and the specific clinical purpose. For instance, the dose is different for adults versus children, is often weight-based for infants, or may be adjusted according to the specific nutritional requirements being addressed.

Q: Is Zinga addictive?

A: Official regulatory documentation and classifications confirm that Zinga (Zinc Sulfate Monohydrate) is not classified as a controlled substance and is not associated with risks of physical dependence or addiction.

Q: Are there any known Zinga interactions with common cold medicine?

A: Official documents outline key interactions, including effects on the body's processing enzymes (like CYP enzymes) and absorption interactions (e.g., with specific antibiotics like tetracyclines and quinolones). Due to the variety of ingredients in cold medicines, it is important to check if their active ingredients overlap with the documented interaction categories.

Q: How does Zinga affect mental clarity?

A: The regulatory side effect profile for Zinga does list general Nervous System Disorders, including specific reports of headache and irritability. However, official information does not explicitly describe effects on 'mental clarity' or 'focus' but notes these broader central nervous system effects.

Q: Why do doctors prescribe Zinga instead of other options?

A: Zinga is prescribed primarily based on its official classification as an essential trace element supplement. This means its use is typically intended to correct or prevent elemental zinc deficiency, which is a distinct therapeutic goal separate from drug classes that treat disease symptoms or pathology.

How should Zinga be stored and disposed of?

Storage & Disposal Map: How to Store and Dispose of Zinga — Official Regulatory Information


Storage & disposal scope

Labeled storage temperature requirements: Must be stored in a cool and dry environment with temperatures between 5 C and 30 C. Must be protected from extreme heat and freezing temperatures.

Light/moisture protection requirements: Keep away from direct sunlight and ensure the container is tightly closed to prevent moisture intrusion and vapor release.

Stability after opening/reconstitution (if applicable): The product remains stable if the container is resealed and stored correctly. The official shelf-life is unlimited if the unopened container is mechanically shaken periodically.

Handling requirements: Must be kept away from heat, hot surfaces, sparks, open flames, and other ignition sources due to its flammability classification. Store in a well-ventilated area.

Disposal instructions (as documented in government sources): Disposal of the contents and container must be completed in accordance with all local, regional, and national regulations. Containers should be drained thoroughly and sent to a metal reclaimer.

Environmental or controlled-waste disposal requirements (if applicable): Must be prevented from entering drains and waterways. The product is classified as hazardous waste and should be taken to a special waste collection point.

Child-protection storage requirements (if stated): The official label contains a mandate to Keep out of reach of children and Store locked up.


Connection to the overall storage/disposal profile

Regulatory documents define strict constraints for Zinga's storage, mandating a controlled temperature range and separation from all ignition sources due to its flammability classification. The official labeling requires protection from direct sunlight and moisture by keeping the container tightly closed to maintain product stability. Furthermore, regulatory statements classify the product as environmentally hazardous waste, defining disposal rules that prohibit disposal into household waste or waterways, requiring proper collection and handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zinga found in:

A-Z Index: